|
Inflacam
|
5 mg/ml
|
EU/2/11/134/016
|
Chanelle Pharmaceuticals Manufacturing Ltd., Īrija
|
QM01AC06
|
dogs; cats
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
solution for injection
|
| International name (active substance): |
Meloxicam
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Chanelle Pharmaceuticals Manufacturing Ltd., Īrija
|
| Date of authorisation/renewal: |
09-Nov-2016
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/11/134/016 |
5 mg/ml |
1 |
Flakons, 20 ml |
-
|
|
|
Synulox Tabletki 50 mg
|
-
|
V/I/25/0041
|
Zoetis Belgium S.A., Beļģija
|
QJ01CR02
|
dogs; cats
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
tablets
|
| International name (active substance): |
Amoxicillin trihydrate, Potassium clavulanate
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Haupt Pharma Latina S.R.L., Itālija
|
| Date of authorisation/renewal: |
05-Jun-2025
|
| Marketing authorisation valid until: |
04-Jun-2030
|
| Marketing authorisation procedure: |
I
|
| Package leaflet: |
[DOCX] 04062025LI (04-Jun-2025)
|
| Labelling text: |
See products section
|
| Summary of product characteristics: |
-
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/I/25/0041-01 |
|
1 |
Blisteris, 10 tablete |
[PDF]
|
|
|
Veraflox
|
25 mg/ml
|
EU/2/10/107/014
|
Bayer Animal Health , Vācija
|
QJ01MA97
|
cats
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
suspension for oral use
|
| International name (active substance): |
Pradofloxacin
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
KVP Pharma + Veterinar Produkte GmbH, Vācija
|
| Date of authorisation/renewal: |
07-Jan-2016
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/10/107/014 |
25 mg/ml |
1 |
Pudelīte (caurspīdīga), 30 ml |
-
|
|
|
Simparica
|
10 mg/tabl.
|
EU/2/15/191/004
|
Zoetis Belgium S.A., Beļģija
|
QP53BE03
|
dogs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
chewable tablets
|
| International name (active substance): |
Sarolaner
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Zoetis Belgium S.A., Beļģija
|
| Date of authorisation/renewal: |
12-Aug-2020
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/15/191/004 |
|
1 |
Al/Al blisteris, 1 tablete |
-
|
|
|
Porcilis PCV
|
-
|
EU/2/08/091/008
|
Intervet International B.V., Nīderlande
|
QI09AA07
|
pigs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
emulsion for injection
|
| International name (active substance): |
Inactivated recombinant Porcine Circovirus type 2
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Intervet International B.V., Nīderlande
|
| Date of authorisation/renewal: |
14-Jan-2014
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/08/091/008 |
|
10 |
Pudelīte, 100 ml |
-
|
|
|
Credelio
|
225 mg
|
EU/2/17/206/009
|
Elanco GmbH, Vācija
|
QP53BE04
|
dogs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
chewable tablets
|
| International name (active substance): |
Lotilaner
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Elanco France S.A.S, Francija
|
| Date of authorisation/renewal: |
26-Apr-2022
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/17/206/009 |
225 mg |
1 |
Alumīnija blisteris, 6 tablete |
-
|
|
|
BRAVECTO TriUNO
|
-
|
EU/2/24/325/011
|
Intervet International B.V., Nīderlande
|
QP54AB52
|
dogs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
Chewable tablet
|
| International name (active substance): |
Fluralaner, Moxidectin, Pyrantel
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
-
|
| Date of authorisation/renewal: |
22-Nov-2024
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/24/325/011 |
|
3 |
Blisteris, 1 tablete |
-
|
|
|
Zolvix
|
25 mg/ml
|
EU/2/09/101/006
|
Elanco GmbH, Vācija
|
QP52AX09
|
sheep
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
solution for oral use
|
| International name (active substance): |
Monepantel
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Elanco France S.A.S, Francija;Vericore Ltd., Lielbritānija
|
| Date of authorisation/renewal: |
03-Nov-2014
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/09/101/006 |
25 mg/ml |
1 |
Plastmasas pudele, 1 l |
-
|
|
|
Pexion
|
100 mg
|
EU/2/12/147/006
|
Boehringer Ingelheim Vetmedica GmbH, Vācija
|
QN03AX
|
dogs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
tablets
|
| International name (active substance): |
Imepitoin
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Boehringer Ingelheim Vetmedica GmbH, Vācija
|
| Date of authorisation/renewal: |
27-Nov-2017
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/12/147/006 |
100 mg |
30 |
Polietilēna pudele, 30 tablete |
-
|
|
|
EVICTO
|
15 mg
|
EU/2/19/242/001
|
VIRBAC, Francija
|
QP54AA05
|
cats ≤ 2,5 kg; dogs ≤ 2,5 kg
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
spot-on solution
|
| International name (active substance): |
Selamectin
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
VIRBAC, Francija
|
| Date of authorisation/renewal: |
19-Jul-2019
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/19/242/001 |
60 mg/ml |
1 |
Polipropilēna pipete, 0,25 ml |
-
|
|
|
PREVEXXION RN+HVT
|
0.2 ml
|
EU/2/23/302/003
|
Boehringer Ingelheim Vetmedica GmbH, Vācija
|
QI01AD03
|
chickens
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
concentrate and solvent for suspension for injection
|
| International name (active substance): |
Cell-associated live recombinant Marek’s disease (MD) virus, serotype 1,strain RN1250, Cell-associated, live attenuated Marek’s disease (MD) virus, serotype 3,strain HVT FC126
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Boehringer Ingelheim Animal Health France SCS , Francija
|
| Date of authorisation/renewal: |
24-Oct-2023
|
| Marketing authorisation valid until: |
23-Oct-2028
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/23/302/003 |
|
4 |
Stikla ampula, 4000 deva |
-
|
|
|
Cortavance
|
0.584 mg/ml
|
EU/2/06/069/002
|
Virbac S.A., Francija
|
QD07AC16
|
dogs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
cutaneous spray, solution
|
| International name (active substance): |
Hydrocortisone aceponate
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Virbac S.A., Francija
|
| Date of authorisation/renewal: |
13-Sep-2011
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/06/069/002 |
0,584 mg/ml |
1 |
Polietilēna pudelīte, 31 ml |
-
|
|
|
Metacam
|
5 mg/ml
|
EU/2/97/004/006
|
Boehringer Ingelheim Vetmedica GmbH, Vācija
|
QM01AC06
|
dogs; cats
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
solution for injection
|
| International name (active substance): |
Meloxicam
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Labiana Life Sciences S.A., Spānija
|
| Date of authorisation/renewal: |
06-Dec-2007
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/97/004/006 |
5 mg/ml |
1 |
Stikla flakons, 10 ml |
-
|
|
|
VEPURED
|
-
|
EU/2/17/214/001
|
Laboratorios Hipra S.A., Spānija
|
QI09AB02
|
pigs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
suspension for injection
|
| International name (active substance): |
Recombinant verotoxin 2e of E. coli
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Laboratorios Hipra S.A., Spānija
|
| Date of authorisation/renewal: |
22-Jul-2022
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/17/214/001 |
|
1 |
Polietilēna flakons, 10 deva |
-
|
|
|
Loxicom
|
2.5 mg
|
EU/2/08/090/023
|
Norbrook Laboratories (Ireland) Limited, Īrija
|
QM01AC06
|
dogs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
chewable tablets
|
| International name (active substance): |
Meloxicam
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Norbrook Laboratories Limited, Lielbritānija
|
| Date of authorisation/renewal: |
12-Mar-2014
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/08/090/023 |
2,5 mg |
1 |
Blisteris, 10 tablete |
-
|
|
|
Prac-tic
|
275 mg
|
EU/2/06/066/008
|
Elanco GmbH, Vācija
|
QP53AX26
|
dogs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
spot-on solution
|
| International name (active substance): |
Pyriprole
|
| Distribution category: |
Nonprescription veterinary medicinal product
|
| Manufacturer(s) responsible for batch release |
Elanco France S.A.S, Francija
|
| Date of authorisation/renewal: |
16-Nov-2011
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/06/066/008 |
275 mg/deva |
6 |
Pipete, 1 deva |
-
|
|
|
APOQUEL
|
5.4 mg
|
EU/2/13/154/024
|
Zoetis Belgium S.A., Beļģija
|
QD11AH90
|
dogs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
film-coated tablets
|
| International name (active substance): |
Oclacitinib
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Zoetis Belgium S.A., Beļģija;Pfizer Italia S.R.L., Itālija
|
| Date of authorisation/renewal: |
13-Dec-2021
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/13/154/024 |
5,4 mg |
10 |
Blisteris, 10 tablete |
-
|
|
|
Canigen L4
|
-
|
EU/2/15/183/002
|
Intervet International B.V., Nīderlande
|
QI07AB01
|
dogs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
suspension for injection
|
| International name (active substance): |
L. interrogans serogroup Canicola serovar Portland-vere (strain Ca-12-000),L. interrogans serogroup Icterohaemorrhagiae serovar Copenhageni (strain Ic-02-001),L. interrogans serogroup Australis serovar Bratislava (strain As-05-073),L. kirschneri serogroup Grippotyphosa serovar Dadas (strain Gr-01-005)
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Intervet International B.V., Nīderlande
|
| Date of authorisation/renewal: |
02-Jul-2020
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/15/183/002 |
|
50 |
Stikla flakons, 1 deva |
-
|
|
|
Melovem
|
30 mg/ml
|
EU/2/09/098/005
|
Dopharma Research B.V., Nīderlande
|
QM01AC06
|
cattle; pigs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
solution for injection
|
| International name (active substance): |
Meloxicam
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Dopharma B.V., Nīderlande
|
| Date of authorisation/renewal: |
06-Jun-2014
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/09/098/005 |
30 mg/ml |
1 |
Stikla flakons, 50 ml |
-
|
|
|
Trilorale
|
50 mg/ml
|
EU/2/24/313/005
|
Axience, Francija
|
QH02CA01
|
dogs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
Oral solution
|
| International name (active substance): |
Trilostane
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
-
|
| Date of authorisation/renewal: |
06-May-2024
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/24/313/005 |
50 mg/ml |
1 |
Polipropilēna pudele, 36 ml |
-
|
|